Pure Biologics S.A. (WSE: PUR)
Poland flag Poland · Delayed Price · Currency is PLN
17.98
+0.18 (1.01%)
Nov 22, 2024, 5:00 PM CET

Pure Biologics Revenue

Pure Biologics had revenue of 250.00K PLN in the quarter ending September 30, 2024, with 346.43% growth. This brings the company's revenue in the last twelve months to 312.00K, up 294.94% year-over-year. In the year 2023, Pure Biologics had annual revenue of 95.00K, down -85.65%.

Revenue (ttm)
312.00K
Revenue Growth
+294.94%
P/S Ratio
146.15
Revenue / Employee
78.00K
Employees
51
Market Cap
66.39M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202395.00K-567.00K-85.65%
Dec 31, 2022662.00K408.00K160.63%
Dec 31, 2021254.00K-318.00K-55.59%
Dec 31, 2020572.00K-1.20M-67.79%
Dec 31, 20191.78M500.49K39.24%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Krka, d. d. 8.14B
NEUCA S.A. 12.34B
Sopharma AD 4.35B
Celon Pharma S.A. 206.81M
Synektik Spólka Akcyjna 624.80M
Voxel S.A. 476.19M
Ryvu Therapeutics S.A. 91.18M
Selvita S.A. 329.02M
Revenue Rankings